Literature DB >> 30507437

Defining priority medical devices for cancer management: a WHO initiative.

Adriana Velazquez Berumen1, Gabriela Jimenez Moyao2, Natalia M Rodriguez3, André M Ilbawi4, Antonio Migliore5, Lawrence N Shulman6.   

Abstract

Medical devices are indispensable for cancer management across the entire cancer care continuum, yet many existing medical interventions are not equally accessible to the global population, contributing to disparate mortality rates between countries with different income levels. Improved access to priority medical technologies is required to implement universal health coverage and deliver high-quality cancer care. However, the selection of appropriate medical devices at all income and hospital levels has been difficult because of the extremely large number of devices needed for the full spectrum of cancer care; the wide variety of options within the medical device sector, ranging from small inexpensive disposable devices to sophisticated diagnostic imaging and treatment units; and insufficient in-country expertise, in many countries, to prioritise cancer interventions and to determine associated technologies. In this Policy Review, we describe the methods, process, and outcome of a WHO initiative to define a list of priority medical devices for cancer management. The methods, approved by the WHO Guidelines Review Committee, can be used as a model approach for future endeavours to define and select medical devices for disease management. The resulting list provides ready-to-use guidance for the selection of devices to establish, maintain, and operate necessary clinical units within the continuum of care for six cancer types, with the goal of promoting efficient resource allocation and increasing access to priority medical devices, particularly in low-income and middle-income countries.
Copyright © 2018 World Health Organization. Published by Elsevier Ltd. All rights reserved. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30507437     DOI: 10.1016/S1470-2045(18)30658-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  3 in total

1.  Cancer Classification at the Crossroads.

Authors:  Antonino Carbone
Journal:  Cancers (Basel)       Date:  2020-04-15       Impact factor: 6.639

Review 2.  Caspase-Independent Regulated Necrosis Pathways as Potential Targets in Cancer Management.

Authors:  Jianyao Lou; Yunxiang Zhou; Zengyu Feng; Mindi Ma; Yihan Yao; Yali Wang; Yongchuan Deng; Yulian Wu
Journal:  Front Oncol       Date:  2021-02-16       Impact factor: 6.244

3.  The Evolving Landscape of Medical Device Regulation in East, Central, and Southern Africa.

Authors:  Sarah Hubner; Caroline Maloney; Sarah Dunn Phillips; Pratik Doshi; Julius Mugaga; Robert Tamale Ssekitoleko; Jenna L Mueller; Tamara N Fitzgerald
Journal:  Glob Health Sci Pract       Date:  2021-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.